Sun Pharmaceuticals reported INR21.51B in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aspen Pharmacare APN:SJ 4.56B 1.01B
Bharat Petroleum BPCL:IN 45.32B 11.07B
Cipla CIPLA:IN 8.89B 4.87B
Dr.Reddys Laboratories DRRD:IN 6.39B 4.81B
Jiangsu Hengrui Me. 600276:CH CH 1.37B 1.77B
Reliance Infra RELI:IN 290.51B 56.86B
Sh Fosun Pharma 600196:CH CH 895.95M 718.57M
Sun Pharmaceuticals SUNP:IN IR 21507.2M 44635.9M
UPL UPLL:IN 16.77B 11.05B